EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Navigating the AI Transformation in Healthcare

    Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration

KNOWLEDGE BANK

  • Articles

    Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus

    Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect

    B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority

    The pharmaceutical industry has never been short of innovation Every year brings breakthroughs in biologics advanced therapies AIdriven drug discovery manufacturing automation precision medicine and digital health

    Top 10 Pharmaceutical Blogs and Publications in Europe

    The pharmaceutical industry in Europe operates as one of the worlds most developed and firmly controlled sectors The maintenance of present industry trends alongside research and policies and innovations represents a key requirement for serving professionals within this field The key to industrial progress depends on trustworthy pharmaceutical research obtained through industryleading blogs alongs...

    How Digitalization Improves Pharma Manufacturing and Compliance

    The pharmaceutical industry has been at a crossroads where the digitalization process is transforming the way drugs are developed manufactured and monitored Pharmaceutical companies are capitalizing on the power of digitalization in pharmaceutical production to maximize production improve traceability and regulatory compliance due to the tough regulatory requirements and the demand for absolute pr...

    Fundamentals of Pharmaceutical Formulation Development

    The process of changing an active drug substance into a safe and effective drug is much more complicated than it seems at first sight The core of this undertaking is pharmaceutical formulation development a science and strategic field that unites the pursuit of striking a scientific breakthrough and patient care Even the most promising drug molecule would not confer therapeutic benefits without be...

    Advancements in Spray Drying for Pharmaceutical Formulations

    Spray drying has emerged as a critical technique in the pharmaceutical industry revolutionizing the formulation process Traditional methods for converting liquid solutions into powder form were timeconsuming and lacked control over particle properties

TOP ARTICLES

  • 2

    Top 10 Pharmaceutical Blogs and Publications in Europe

    Kate Williamson

    Knowledge remains essential for dealing with the highly regulated pharmaceutical industry found across Europe. This article provides a list of expert pharmaceutical blogs along with publications which...

  • 4

    Fundamentals of Pharmaceutical Formulation Development

    Kate Williamson

    Drug innovation is a principal responsibility of pharmaceutical formulation development that provides the drug with stability, bioavailability, and adherence in the patients. Researchers can make mole...

press releases Read more...

AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical

AstraZeneca has entered into an exclusive license agreement with Dizal Pharmaceutical Co Ltd for Zegfrovy sunvozertinib a novel oral irreversible epidermal growth factor receptor EGFR inhibitor for patients

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business

Servier an independent international pharmaceutical group governed by a foundation today announced that it has completed the acquisition of the muscular dystrophy business of Edgewise Therapeutics Inc

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

Bristol Myers Squibb NYSE BMY today announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for mezigdomide in combination with carfilzomib

Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus

Santhera Pharmaceuticals today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE vamorolone extending the partnership to include Georgia Kazakhstan Belarus

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

26 - 30

Jul 2026

ADLM 2026

Anaheim, CA USA

27 - 28

Jul 2026

27 - 28

Jul 2026

27 - 28

Jul 2026

LATEST NEWS Read more...

Armata Pharmaceuticals Secures FDA Agreement on Initial Paediatric Study Plan for AP-SA02

Armata Pharmaceuticals has received agreement from the US Food and Drug Administration FDA on its Initial Paediatric Study Plan iPSP for APSA supporting the future evaluation of the investigational

DA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Disease Treatment

Eisai and Biogen have received approval from the US Food and Drug Administration FDA for a supplemental Biologics License Application sBLA for LEQEMBI IQLIK lecanemabirmb a onceweekly subcutaneous injection for the initiation treatment of early Alzheimers disease

Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial for Idiopathic Pulmonary Fibrosis

Celea Therapeutics has dosed the first patient in the global Phase SURPASSIPF trial evaluating deupirfenidone as a treatment for idiopathic pulmonary fibrosis IPF The study will compare deupirfenidone mg

Evaxion Presents New Preclinical Data Supporting EVX-V1 Cytomegalovirus Vaccine Programme

Evaxion AS has presented new preclinical data supporting its cytomegalovirus CMV vaccine programme EVXV at the International Herpesvirus Workshop IHW in Montreal Canada

Roche receives CE Mark for blood test to identify tuberculosis infection

Roche has received CE Mark approval for its Elecsys IGRA TB test expanding its tuberculosis TB diagnostics portfolio with a new blood test designed to identify tuberculosis infection TBI also known as latent TB in routine laboratory settings

LEO Pharma reports positive Phase 2 trial results for tralokinumab in children with atopic dermatitis

LEO Pharma has announced positive results from the Phase TRAPEDS trial which evaluated the pharmacokinetics and safety of tralokinumab in children aged to years with moderatetosevere atopic dermatitis